Roche Holding AG filled a trispecific antibody-sized hole in its B-cell disease franchise by bringing in Simcere Zaiming Pharmaceutical Co. Ltd.’s SIM-0600, a preclinical CD79a/CD19/CD3-targeting ...
Mutations associated with autism spectrum disorder (ASD) alter the physical interactions between proteins. To understand how ...
Bloodstream infections are a leading cause of sepsis, a dysregulated immune response leading to systemic inflammation, organ ...
Acute myocardial infarction (AMI) represents a global health risk and is associated with high mortality and morbidity, with about 17 million annual deaths worldwide. Reperfusion therapy improves the ...
Biopharma and med-tech company deals and M&As: Abbott, Alvotech, Ambros, Amplitude, Avricore, Beyond Air, Bioarctic, BMS, Chai Discovery, Chong Kun Dang, Darmiyan ...
Remedium Bio Inc. has announced the initial closing of its planned $10 million series A financing as it advances its durable protein therapeutics platform toward first-in-human development.
A compound targeting serotonin receptor 5-HT2A (5-HT2AR) signaling in the gut could activate antitumor immunity in colorectal cancer (CRC) and improve responses to immunotherapy without causing ...
Innovstone Therapeutics Ltd. has synthesized cathepsin C (dipeptidyl peptidase I; DPP-1) inhibitors found to be potentially useful for the treatment of autoimmune diseases and cancer.
An increase in the level of M&A activity and some sizeable financing rounds are encouraging signs for the med-tech investment environment, said Joey Mason, life sciences venture partner at Claret ...
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain barrier-penetrant AAV9 gene therapy ...
New research has teased out specific aspects of how Epstein-Barr virus (EBV) sparks the immune response that leads on to the development of multiple sclerosis (MS), opening the way to the rational ...
BioWorld - Sunday, August 30, 2026 Breaking News: Best of BioWorld Science: Q2 See today's BioWorld Science Home » BioWorld Science » Nampt inhibitors reported in Alphina Therapeutics patent To read ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results